Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation

American Journal of Dermatopathology

Volumn 21, Issue 1, 1999, Pages 77-81

  Lin, J D ^a   Chao, T C ^a   Huang, M J ^a   Weng, H F ^a   Tzen, K Y ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Follicular thyroid carcinoma; Papillary thyroid carcinoma; Subtotal thyroidectomy; Thyroglobulin

Indexed keywords

EID: 33646946480     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Baldet L, Manderscheid JC, Glinoer D, Jafflol C, Coste Seignovert B, Percheron C. The management of differentiated thyroid cancer in Europe in 1988. Results of an international survey. Acta Endocrinol (Copenhagen) 1989; 120:547-58.
2. Van De Velde CJH, Hamming JF, Goslings BM, et al. Report of the consensus development conference on the management of differentiated thyroid cancer in The Netherlands. Eur J Cancer Oncol 1988;24:287-92.
3. Lin JD, Hsueh C, Chao TC, Weng HF, Huang BY. Thyroid follicular neoplasm diagnosed by high resolution ultrasonography with fine needle aspiration cytology. Acta Cytol (in press).
4. Rosen Y, Rosenblatt P, Saltzman E. Intraoperative pathologie diagnosis of thyroid neoplasms. Report on experience with 504 specimens. Cancer 1990;66:2001-6.
5. Shaha AR, DiMaio T, Webber C, Jaffe BM. Introperative decision making during thyroid surgery based on the results of preoperative needle biopsy and frozen section. Surgery 1990; 108:964-7.
6. Wax MK, Briant TDR. Completion thyroidectomy in the man-agement of well-differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1992; 107:63-8.
7. De Jong SA, Demeter JG, Lawrence AM, Paloyan E. Necessity and safety of completion thyroidectomy for differentiated thyroid carcinoma. Surgery 1992; 112:734-9.
8. Hay ID, Grand CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102:1088-95.
9. Rao RS, Jog VB, Baluja CA, Damle SR. Risk of hypoparathyroidism after surgery for carcinoma of the thyroid. Head Neck 1990; 12:321-5.
10. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning métastases of adenocarcinoma of thyroid. JAMA 1946;132:838-47.
11. Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? Mayo Clin P roc 1991 ;66:105-11.
12. Goolden AWG. The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer. Clin Endocrinol 1985;23:81-6.
13. Beierwaltes WH, Rabbani R, Dmuchowski C, et al. An analysis of "ablation of thyroid remnants" with 1-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med 1984; 25:1287-93.
14. 131I ablation following thyroidectomy in patients with invasive follicular thyroid cancer. Am J Surg 1992; 163:472-5.
15. 131I). Ann Surg 1994:219:587-95.
16. O'doherty MJ, Nunan TO, Croft DN. Radionuclides and therapy of thyroid cancer. Nncl Med Commun 1993; 14:736-55.
17. Bal C, Padhy AK, Jana S, Pant GS, Basu AK. Prospective randomized clinical trial to evaluate the optimal dose of 1311 for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996; 77:2574-80.
18. Liu RT, Huang MJ, Huang HS et al. Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation. J Formosan Med Assoc 1987;86:524-8.
19. Lin JD, Huang MJ, Huang BY, Huang HS, Jeng LB. Thyroid cancer treated in Chang Gung Memorial Hospital (Northern Taiwan), during the period: 1979-1992: Clinical presentation, pathological finding, analysis of prognostic variables and results of treatment. J Surg Oncol 1994; 57:244-55.
20. Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenoma and encapsulated follicular carcinomas in thyroid gland. Virchows Arch 1980;385:125-41.
21. Johansen K, Woodhouse NJY, Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nud Med I991;32:252-4.